EZZ Life Science Holdings Ltd (EZZ) — Cash Flow Quality Index
EZZ Life Science Holdings Ltd (EZZ) has a Cash Flow Quality Index of 0.81x as of June 2025. Operating cash flow of AU$2.86 Million is below net income of AU$3.53 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore EZZ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
EZZ Life Science Holdings Ltd Cash Flow Quality Index (2018–2024)
Historical Cash Flow Quality Index for EZZ Life Science Holdings Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see EZZ operating cash flow.
Annual Cash Flow Quality Index for EZZ Life Science Holdings Ltd (2018–2024)
Year-by-year earnings quality comparison for EZZ Life Science Holdings Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.65x | AU$4.35 Million | AU$6.73 Million | ▼ -26.7% |
| 2023 | 0.88x | AU$6.14 Million | AU$6.96 Million | ▼ -20.2% |
| 2022 | 1.11x | AU$4.01 Million | AU$3.63 Million | ▼ -23.7% |
| 2021 | 1.45x | AU$1.90 Million | AU$1.31 Million | ▲ +1060.6% |
| 2020 | 0.12x | AU$253.53K | AU$2.03 Million | ▼ -93.3% |
| 2019 | 1.88x | AU$2.97 Million | AU$1.59 Million | ▲ +271.1% |
| 2018 | 0.51x | AU$416.33K | AU$823.81K | — |